Unrelated bone marrow transplantation for Epstein–Barr virus-associated T/NK-cell lymphoproliferative disease
Authors:
- 1 January 2003
- journal article
- case report
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 31 (2) , 105-111
Abstract
Epstein–Barr virus (EBV)-associated T/NK-cell lymphoproliferative disease (LPD) has been linked to several different disorders, including chronic active EBV infection, EBV-associated hemophagocytic syndrome, hypersensitivity to mosquito bites, hydroa vacciniforme, aggressive NK-cell leukemia, and nasal/nasal-type NK-cell lymphoma. In most instances, these disorders are refractory to conventional treatments and have a poor prognosis. Here, we report a new treatment strategy for EBV-associated T/NK-cell LPD, consisting of immunochemotherapy, intensive combination chemotherapy, and stem cell transplantation. The five patients studied, two with T-cell and three with NK-cell LPD, lacked a human leukocyte antigen-matched, related donor, and therefore received bone marrow grafts from HLA-matched, unrelated donors. The preconditioning regimen consisted of total-body irradiation (12 Gy), etoposide (900 mg/m2), and cyclophosphamide (120 mg/kg) or melphalan (210 mg/m2). All patients had residual LPD by a quantitative PCR technique prior to transplantation. After unrelated bone marrow transplantation (UBMT), four of the five patients remain in continuous complete remission at a median of 19 months, without detectable EBV-DNA in peripheral blood. Thus, UBMT appears to be a reasonable option for the treatment of patients with EBV-associated T/NK-cell LPD. Detection of EBV-DNA by PCR offers an important tool for assessing minimal residual disease in patients with EBV-associated T/NK-cell LPD.Keywords
This publication has 19 references indexed in Scilit:
- Mosquito allergy and Epstein-Barr virus–associated T/natural killer–cell lymphoproliferative diseaseBlood, 2001
- Epstein–Barr Virus InfectionNew England Journal of Medicine, 2000
- Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation.The Lancet, 2000
- Natural Killer (NK) and T Cell-Associated Surface Marker Expression Following Allogeneic and Autologous Bone Marrow Transplantation (BMT)Journal of Hematotherapy & Stem Cell Research, 2000
- The association of latent Epstein?Barr virus infection with hydroa vacciniformeBritish Journal of Dermatology, 1999
- Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients.Journal of Clinical Oncology, 1998
- Hypersensitivity to Mosquito Bites Conceals Clonal Lymphoproliferation of Epstein‐Barr Viral DNA‐positive Natural Killer CellsJapanese Journal of Cancer Research, 1997
- CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA.Journal of Clinical Investigation, 1989
- T-Cell Lymphomas Containing Epstein–Barr Viral DNA in Patients with Chronic Epstein–Barr Virus InfectionsNew England Journal of Medicine, 1988
- The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferationCell, 1986